ReviewTherapeutic advances in chronic disease2015

Vedolizumab: an α4β7 integrin antagonist for ulcerative colitis and Crohn's disease.

Lauren N Cherry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.